AHA Comments on HHS on 340B Program Proposals

AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

Key Resources

Related Resources

Letter/Comment
AHA Submits Comments on CMS Guidance For Medicare Drug Price Negotiation Program
Public
Letter/Comment
AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions
Public
Letter/Comment
AHA Letter to House Energy and Commerce Committees on Value of 340B Program
Public
Action Alert
Contact your Representative Prior to June 4 House Subcommittee Hearing on 340B
Member Non-Fed
AHA Center for Health Innovation Market Scan
3 Ways GLP-1 Drugs Could Impact Your Hospital’s Future
Advisory
HRSA Finalizes 340B Administrative Dispute Resolution Process
Member